Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA A-770041 GDSC1000 pan-cancer AAC 0.081 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.2
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.048 0.2
mRNA BX-912 GDSC1000 pan-cancer AAC 0.045 0.2
mRNA alisertib CTRPv2 pan-cancer AAC 0.047 0.2
mRNA ML312 CTRPv2 pan-cancer AAC 0.11 0.2
mRNA PX-12 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.052 0.2
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.072 0.2
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.053 0.2
Download CSV